EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Precision-Cut Liver Slices: A Valuable Preclinical Tool for Translational Research in Liver Fibrosis

Meritxell Perramón iD, Manuel Macías-Herranz, Rocío García-Pérez, Wladimiro Jiménez iD, Guillermo Fernández-Varo iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26167780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Meritxell Perramón und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Genetics Service, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 …. Hauptthemen laut MEDLINE: Translational Research, Biomedical, Liver Cirrhosis, Liver, Tissue Culture Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MCIN/AEI/10.13039/501100011033 and by the European Union Next Generation EU/PRTR, MCIN/AEI/10.13039/501100011033/ and by FEDER Una manera de hacer Europa, Instituto de Salud Carlos III and by the European Regional Development Fund, European Union, "A way to make Europe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Halting liver fibrosis progression is a key goal in treating liver disease, yet effective antifibrotic drugs remain unavailable. This study explores the use of precision-cut liver slices (PCLS) as an ex vivo model to evaluate new therapies. Researchers tested how different oxygen levels affect viability, tissue integrity, and inflammatory response in PCLS from healthy and fibrotic rats. Fibrotic PCLS maintained their pathological gene signature under 40% oxygen and responded to inflammatory stimuli, indicating preserved functionality. Exposure to high oxygen levels increased oxidative stress and pro-inflammatory gene expression. Cirrhotic PCLS showed early signs of reduced viability and the upregulation of fibrosis-related genes including Col1α2, Col3α1, αSMA, Timp1, Timp2, Mmp2, Pdgfrβ, Nos2, Cox2, and Il6. Lipopolysaccharide (LPS) exposure induced the marked overexpression of Nos2 and Il1β mRNA and confirmed the model’s responsiveness to external injury. Fibrotic PCLS retained fibrogenic activity for at least 48 h. Additionally, the adenoviral delivery of a dominant-negative soluble PDGFRβ effectively blocked fibrotic signaling. Human fibrotic PCLS also remained viable for 72 h and showed an increased mRNA expression of fibrosis markers such as COL1A1, αSMA, and MMP2. These results highlight the potential of PCLS as a promising platform for future therapeutic testing, pending further validation with functional interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Translational Research, BiomedicalLiver CirrhosisLiverTissue Culture TechniquesHumansAnimalsRatsBiomarkersHyperoxiaCell SurvivalInflammation MediatorsMaleRats, WistarRNA, MessengerCollagen Type I, alpha 1 ChainActinsMatrix Metalloproteinase 2Oxidative StressOxygen

Stichwörter der Autor:innen

ex vivo model of liver fibrosishyperoxiapathological gene signaturepreclinical toolsrat and human precision cut liver slicestranslational liver research

Substanzen

BiomarkersInflammation MediatorsRNA, MessengerCollagen Type I, alpha 1 ChainActinsMatrix Metalloproteinase 2Oxygen

Autor:innen und Institutionen

  • Biochemistry and Molecular Genetics Service, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), ISCIII, 28029 Madrid, Spain.
  • Department of Biomedicine, University of Barcelona, 08036 Barcelona, Spain.
  • Hepatopancreatobiliary Surgery & Transplantation, General & Digestive Surgery Service, Digestive & Metabolic Disease Institute (ICMDM), Hospital Clínic of Barcelona, 08036 Barcelona, Spain.
  • Department of Medicine, University of Barcelona, 08036 Barcelona, Spain.

ORCID-Profile: Meritxell Perramón, Wladimiro Jiménez, Guillermo Fernández-Varo

Förderung

  • MCIN/AEI/10.13039/501100011033 and by the European Union Next Generation EU/PRTR
  • MCIN/AEI/10.13039/501100011033/ and by FEDER Una manera de hacer Europa
  • Instituto de Salud Carlos III and by the European Regional Development Fund, European Union, "A way to make Europe
  • Instituto de Salud Carlos III and by the European Regional Development Fund, European Union, “A way to make Europe
  • RedFibro
  • The Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), funded by the Instituto de Salud Carlos III

Zitieren

APA

Perramón, M., Macías-Herranz, M., García-Pérez, R., Jiménez, W., & Fernández-Varo, G. (2025). Precision-Cut Liver Slices: A Valuable Preclinical Tool for Translational Research in Liver Fibrosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167780

Vancouver

Perramón M, Macías-Herranz M, García-Pérez R, Jiménez W, Fernández-Varo G. Precision-Cut Liver Slices: A Valuable Preclinical Tool for Translational Research in Liver Fibrosis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167780

BibTeX
@article{Perramn2025,
  author = {Perramón, Meritxell and Macías-Herranz, Manuel and García-Pérez, Rocío and Jiménez, Wladimiro and Fernández-Varo, Guillermo},
  title = {Precision-Cut Liver Slices: A Valuable Preclinical Tool for Translational Research in Liver Fibrosis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26167780}
}
Kostenlos starten →